ALPHA TEKNOVA, INC. Operating Expenses
ALPHA TEKNOVA, INC. (TKNO) reported Operating Expenses of $7.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- ALPHA TEKNOVA, INC. operating expenses for the quarter ending 2026-06-30 was $7.78M, a 5.50% increase year-over-year.
- ALPHA TEKNOVA, INC. operating expenses for the quarter ending 2026-03-31 was $8.08M, a 1.39% increase year-over-year.
- ALPHA TEKNOVA, INC. operating expenses for the quarter ending 2025-12-31 was $7.85M, a 1.25% increase year-over-year.
- ALPHA TEKNOVA, INC. operating expenses for the quarter ending 2025-09-30 was $7.22M, a 3.98% decline year-over-year.
- ALPHA TEKNOVA, INC. operating expenses for fiscal 2025 was $30.42M, a 8.87% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. operating expenses for fiscal 2024 was $33.38M, a 27.22% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. operating expenses for fiscal 2023 was $45.86M, a 31.69% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. operating expenses for fiscal 2022 was $67.14M, a 126.59% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.78M 10-Q · filed 2026-08-06 | $15.86M 10-Q · filed 2026-08-06 | $23.71M derived: sum of 3 quarters · filed 2026-08-06 | $30.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $8.08M 10-Q · filed 2026-05-07 | $15.94M derived: sum of 2 quarters · filed 2026-05-07 | $23.16M derived: sum of 3 quarters · filed 2026-05-07 | $30.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.08M derived: sum of 2 quarters · filed 2026-03-02 | $22.45M derived: sum of 3 quarters · filed 2026-08-06 | $30.42M 10-K · filed 2026-03-02 |
| 2025-09-30 | $7.22M 10-Q · filed 2025-11-07 | $14.59M derived: sum of 2 quarters · filed 2026-08-06 | $22.56M 10-Q · filed 2025-11-07 | $30.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.37M 10-Q · filed 2026-08-06 | $15.34M 10-Q · filed 2026-08-06 | $23.10M derived: sum of 3 quarters · filed 2026-08-06 | $30.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.97M 10-Q · filed 2026-05-07 | $15.73M derived: sum of 2 quarters · filed 2026-05-07 | $23.25M derived: sum of 3 quarters · filed 2026-05-07 | $31.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.28M derived: sum of 2 quarters · filed 2026-03-02 | $23.18M derived: sum of 3 quarters · filed 2026-03-02 | $33.38M 10-K · filed 2026-03-02 |
| 2024-09-30 | $7.52M 10-Q · filed 2025-11-07 | $15.43M derived: sum of 2 quarters · filed 2025-11-07 | $25.62M 10-Q · filed 2025-11-07 | $37.81M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $7.90M 10-Q · filed 2025-08-08 | $18.10M 10-Q · filed 2025-08-08 | $30.29M derived: sum of 3 quarters · filed 2025-08-08 | $40.53M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $10.20M 10-Q · filed 2025-05-09 | $22.39M derived: sum of 2 quarters · filed 2025-05-09 | $32.62M derived: sum of 3 quarters · filed 2025-05-09 | $44.69M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $12.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $22.43M derived: sum of 2 quarters · filed 2025-03-07 | $34.49M derived: sum of 3 quarters · filed 2025-03-07 | $45.86M 10-K · filed 2025-03-07 |
| 2023-09-30 | $10.23M 10-Q · filed 2024-11-08 | $22.30M derived: sum of 2 quarters · filed 2024-11-08 | $33.67M 10-Q · filed 2024-11-08 | $50.01M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $12.06M 10-Q · filed 2024-08-13 | $23.43M 10-Q · filed 2024-08-13 | $39.78M derived: sum of 3 quarters · filed 2024-08-13 | $67.50M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $11.37M 10-Q · filed 2024-05-13 | $27.71M derived: sum of 2 quarters · filed 2024-05-13 | $55.44M derived: sum of 3 quarters · filed 2024-05-13 | $67.31M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $16.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $44.07M derived: sum of 2 quarters · filed 2024-03-27 | $55.94M derived: sum of 3 quarters · filed 2024-03-27 | $67.14M 10-K · filed 2024-03-27 |
| 2022-09-30 | $27.72M 10-Q · filed 2023-11-13 | $39.60M derived: sum of 2 quarters · filed 2023-11-13 | $50.79M 10-Q · filed 2023-11-13 | $60.53M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $11.87M 10-Q · filed 2023-08-11 | $23.07M 10-Q · filed 2023-08-11 | $32.81M derived: sum of 3 quarters · filed 2023-08-11 | $40.96M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $11.19M 10-Q · filed 2023-05-11 | $20.94M derived: sum of 2 quarters · filed 2023-05-11 | $29.09M derived: sum of 3 quarters · filed 2023-05-11 | $34.97M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $17.90M derived: sum of 2 quarters · filed 2023-03-30 | $23.78M derived: sum of 3 quarters · filed 2023-03-30 | $29.63M 10-K · filed 2023-03-30 |
| 2021-09-30 | $8.15M 10-Q · filed 2022-11-14 | $14.03M derived: sum of 2 quarters · filed 2022-11-14 | $19.88M 10-Q · filed 2022-11-14 | $24.66M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.88M 10-Q · filed 2022-08-11 | $11.73M 10-Q · filed 2022-08-11 | $16.51M derived: sum of 3 quarters · filed 2022-08-11 | $19.44M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $5.85M 10-Q · filed 2022-05-12 | $10.63M derived: sum of 2 quarters · filed 2022-05-12 | $13.56M derived: sum of 3 quarters · filed 2022-05-12 | $16.33M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $7.71M derived: sum of 2 quarters · filed 2022-03-18 | $10.47M derived: sum of 3 quarters · filed 2022-03-18 | $13.09M 10-K · filed 2022-03-18 |
| 2020-09-30 | $2.94M 10-Q · filed 2021-11-12 | $5.70M derived: sum of 2 quarters · filed 2021-11-12 | $8.32M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.77M 10-Q · filed 2021-08-13 | $5.38M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |